Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis

This study has been completed.
Information provided by (Responsible Party):
Forest Laboratories Identifier:
First received: August 10, 2010
Last updated: July 11, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)